Nigeria is on a nationwide alert after at least 352 people died during the last three months in a cholera outbreakNigeria’s health ministry has logged more than 6,400 cases of the disease since June. The disease has been found in 12 of Nigeria's 36 states and health officials now fear the di

read more>>

The Ministry of Public Health and Sanitation has received a major boost up in its efforts to fight malaria in the country after the Global Fund announced Ksh 3.06 billion grant to the Kenyan governmentSpeaking during the launch of Affordable Medicines Facility for Malaria (AMFm) in Nairobi Thursda

read more>>

St. Louis Children’s Hospital recently became the first hospital in the country to implant an artificial lungA team of Washington University doctors working at the hospital and led by cardio-thoracic surgeon Dr. Charles Huddleston said the German-made Novalung sLA Membrane Lung saved the lif

read more>>

AUSTIN, Texas -- Luminex Corporation (Nasdaq: LMNX), the worldwide leader in multiplexed solutions, today announced the full commercial launch of its xTAG® Cystic Fibrosis 60 Kit v2, a new diagnostic test that can simultaneously screen a single blood sample for up to 60 cystic fibrosis-causing

read more>>

CAMBRIDGE, Massachusetts -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV(R) (velaglucerase alfa), a human cell line derived enzyme replacement therapy (ERT) for the V

read more>>

FAIRFAX, Va. -- Recognizing that venous interventions may potentially play an important role in treating some patients who suffer from multiple sclerosis -- an incurable, disabling disease -- the Society of Interventional Radiology has issued a position statement indicating its support for high-SI

read more>>

LES ULIS, France -- The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLLThis approval from the FDA Office of Orphan Products Development was granted on August 6th, 2010Chronic lymphocytic l

read more>>

SWIFTWATER, Pa. -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [

read more>>

NOVATO, Calif. -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in Fin

read more>>

Stockholm, Sweden -- Swedish Orphan Biovitrum (STO: SOBI) today announced that the US FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation (ODD) to Kineret® for the treatment of cryopyrin-associated periodic syndromes (CAPSCAPS is a rare autoinflammatory conditi

read more>>